|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 3 February 2004
doi: 10.1242/jcs.00940
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |

Laboratoire Neurobiologie and Transgenese, UPRES-EA 3143, INSERM, 4 rue Larrey, bâtiment Montéclair, CHU 49033 Angers CEDEX, France.
Author for correspondence (e-mail: eyer{at}univ-angers.fr)
Accepted 14 October 2003
Neurofilaments are synthesised and assembled in neuronal cell bodies, transported along axons and degraded at the synapse. However, in several pathological situations they aggregate in cell bodies or axons. To investigate their turnover when separated from their normal site of degradation, we used a previously described transgenic model characterised by perikaryal retention of neurofilaments, and compared the basic features of both neurofilament synthesis and degradation with that observed in normal mice. Despite the massive perikaryal aggregates, neurofilament transcript levels were found to be unchanged, whereas the total accumulation of neurofilament proteins was markedly reduced. Neurofilaments isolated from transgenic samples are more sensitive to both trypsin and
-chymotrypsin mediated proteolysis. Consistent with their greater in vitro sensitivity, trypsin immunolabeling of cell bodies was stronger in transgenic mice. These results show a novel mechanism to regulate the amount of neurofilaments when they abnormally aggregate.
Key words: Neurofilaments, Aggregation, Transgenic mice, Trypsin proteolysis